A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter’s Syndrome
Condition(s):Richter SyndromeLast Updated:January 9, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Richter SyndromeLast Updated:January 9, 2023Recruiting
Condition(s):Endometrial Cancer; Gastric Cancer; Metastatic Castration-resistant Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Urothelial Cancer; Biliary Tract CancerLast Updated:February 28, 2024Recruiting
Condition(s):Neoadjuvant Therapy; High Risk Prostate Cancer; Locally Advanced Prostate Cancer; Intense Endocrine TherapyLast Updated:August 16, 2022Recruiting
Condition(s):Acute Leukemia of Ambiguous Lineage; B Acute Lymphoblastic LeukemiaLast Updated:March 19, 2024Not yet recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:January 17, 2024Recruiting
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:March 15, 2022Not yet recruiting
Condition(s):Leg Injuries; Fracture; EdemaLast Updated:May 16, 2022Recruiting
Condition(s):Hemophagocytic LymphohistiocytosisLast Updated:April 26, 2022Not yet recruiting
Condition(s):Acute Graft Versus Host DiseaseLast Updated:October 10, 2023Recruiting
Condition(s):Drug-induced Liver InjuryLast Updated:April 29, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.